GLP-1 is meant to support a broader weight loss program
However, the high cost and frequent shortages of these FDA-approved drugs have led employers and patients to explore compounded GLP-1 medications as an alternative
Phase 3 trials in obesity, obesity with knee osteoarthritis, and type 2 diabetes have reported results
Learning to discern credible evidence from marketing language is a critical skill
For women, especially post-menopausal women, low B12 levels can have a serious impact on bone health
The study, known as FOCUS, is enrolling 1,500 patients, who will be randomized to receive either placebo or semaglutide in addition to their diabetes medications